Terms: = Ovarian cancer AND PAX5, Q02548, 5079, ENSG00000196092, BSAP
20 results:
1. A Rare Case of ovarian Double-Hit/Diffuse Large B-Cell Lymphoma: A Case Report and Review of Literature.
Urella M; Nwanwene K; Sidda A; Pacioles T
J Investig Med High Impact Case Rep; 2023; 11():23247096231154641. PubMed ID: 36840472
[TBL] [Abstract] [Full Text] [Related]
2. cancer co-opts differentiation of B-cell precursors into macrophage-like cells.
Chen C; Park B; Ragonnaud E; Bodogai M; Wang X; Zong L; Lee JM; Beerman I; Biragyn A
Nat Commun; 2022 Sep; 13(1):5376. PubMed ID: 36104343
[TBL] [Abstract] [Full Text] [Related]
3. Constitutional BRCA1 Methylation and Risk of Incident Triple-Negative Breast cancer and High-grade Serous ovarian cancer.
Lønning PE; Nikolaienko O; Pan K; Kurian AW; Eikesdal HP; Pettinger M; Anderson GL; Prentice RL; Chlebowski RT; Knappskog S
JAMA Oncol; 2022 Nov; 8(11):1579-1587. PubMed ID: 36074460
[TBL] [Abstract] [Full Text] [Related]
4. Modeling oral cancer screening in the United States population.
Cramer JD; Grauer J
Oral Oncol; 2022 Jan; 124():105656. PubMed ID: 34864525
[TBL] [Abstract] [Full Text] [Related]
5. Sleep Characteristics and Risk of ovarian cancer Among Postmenopausal Women.
Liang X; Harris HR; Hendryx M; Shadyab AH; Hale L; Li Y; Crane TE; Cespedes Feliciano EM; Stefanick ML; Luo J
Cancer Prev Res (Phila); 2021 Jan; 14(1):55-64. PubMed ID: 32917642
[TBL] [Abstract] [Full Text] [Related]
6. Perioperative change in CA125 is an independent prognostic factor for improved clinical outcome in advanced ovarian cancer.
Timmermans M; Zwakman N; Sonke GS; Van de Vijver KK; Duk MJ; van der Aa MA; Kruitwagen RF
Eur J Obstet Gynecol Reprod Biol; 2019 Sep; 240():364-369. PubMed ID: 31400565
[TBL] [Abstract] [Full Text] [Related]
7. Tibolone and risk of gynecological hormone sensitive cancer.
Løkkegaard ECL; Mørch LS
Int J Cancer; 2018 Jun; 142(12):2435-2440. PubMed ID: 29349823
[TBL] [Abstract] [Full Text] [Related]
8. Hysterectomy, Oophorectomy, and Risk of Thyroid cancer.
Luo J; Hendryx M; Manson JE; Liang X; Margolis KL
J Clin Endocrinol Metab; 2016 Oct; 101(10):3812-3819. PubMed ID: 27459531
[TBL] [Abstract] [Full Text] [Related]
9. Hodgkin lymphoma as a novel presentation of familial DICER1 syndrome.
Kuhlen M; Hönscheid A; Schemme J; Merz H; Mauz-Körholz C; Borkhardt A; Troeger A
Eur J Pediatr; 2016 Apr; 175(4):593-7. PubMed ID: 26526666
[TBL] [Abstract] [Full Text] [Related]
10. Diffuse large B-cell lymphoma occurring in an ovarian cystic teratoma: expanding the spectrum of large B-cell lymphoma associated with chronic inflammation.
Valli R; Froio E; Alvarez de Celis MI; Mandato VD; Piana S
Hum Pathol; 2014 Dec; 45(12):2507-11. PubMed ID: 25439346
[TBL] [Abstract] [Full Text] [Related]
11. Dietary cadmium exposure and risk of breast, endometrial, and ovarian cancer in the Women's Health Initiative.
Adams SV; Quraishi SM; Shafer MM; Passarelli MN; Freney EP; Chlebowski RT; Luo J; Meliker JR; Mu L; Neuhouser ML; Newcomb PA
Environ Health Perspect; 2014 Jun; 122(6):594-600. PubMed ID: 24633137
[TBL] [Abstract] [Full Text] [Related]
12. The impact of risk-reducing hysterectomy and bilateral salpingo-oophorectomy on survival in patients with a history of breast cancer--a population-based data linkage study.
Obermair A; Youlden DR; Baade PD; Janda M
Int J Cancer; 2014 May; 134(9):2211-22. PubMed ID: 24127248
[TBL] [Abstract] [Full Text] [Related]
13. DAXX silencing suppresses mouse ovarian surface epithelial cell growth by inducing senescence and DNA damage.
Pan WW; Yi FP; Cao LX; Liu XM; Shen ZF; Bu YQ; Xu Y; Fan HY; Song FZ
Gene; 2013 Sep; 526(2):287-94. PubMed ID: 23542781
[TBL] [Abstract] [Full Text] [Related]
14. Methylation analysis of tumour suppressor genes in ovarian cancer using MS-MLPA.
Chmelařová M; Křepinská E; Spaček J; Laco J; Nekvindová J; Palička V
Folia Biol (Praha); 2012; 58(6):246-50. PubMed ID: 23438850
[TBL] [Abstract] [Full Text] [Related]
15. Hormone therapy and different ovarian cancers: a national cohort study.
Mørch LS; Løkkegaard E; Andreasen AH; Kjaer SK; Lidegaard O
Am J Epidemiol; 2012 Jun; 175(12):1234-42. PubMed ID: 22517811
[TBL] [Abstract] [Full Text] [Related]
16. Predictive value of symptoms for ovarian cancer: comparison of symptoms reported by questionnaire, interview, and general practitioner notes.
Lim AW; Mesher D; Gentry-Maharaj A; Balogun N; Jacobs I; Menon U; Sasieni P
J Natl Cancer Inst; 2012 Jan; 104(2):114-24. PubMed ID: 22247022
[TBL] [Abstract] [Full Text] [Related]
17. Hormone therapy and ovarian borderline tumors: a national cohort study.
Mørch LS; Løkkegaard E; Andreasen AH; Kjær SK; Lidegaard Ø
Cancer Causes Control; 2012 Jan; 23(1):113-20. PubMed ID: 22037908
[TBL] [Abstract] [Full Text] [Related]
18. Trends in incidence of borderline ovarian tumors in Denmark 1978-2006.
Hannibal CG; Huusom LD; Kjaerbye-Thygesen A; Tabor A; Kjaer SK
Acta Obstet Gynecol Scand; 2011 Apr; 90(4):305-12. PubMed ID: 21306323
[TBL] [Abstract] [Full Text] [Related]
19. Characterization of a new monoclonal antibody against pax5/BASP in 1525 paraffin-embedded human and animal tissue samples.
Agostinelli C; Sabattini E; Gjørret JO; Righi S; Rossi M; Mancini M; Piccaluga PP; Bacci F; Marafioti T; Bettini G; Falini B; Pileri SA
Appl Immunohistochem Mol Morphol; 2010 Dec; 18(6):561-72. PubMed ID: 20697266
[TBL] [Abstract] [Full Text] [Related]
20. A case-control study of dietary and nondietary factors in ovarian cancer.
Byers T; Marshall J; Graham S; Mettlin C; Swanson M
J Natl Cancer Inst; 1983 Oct; 71(4):681-6. PubMed ID: 6578362
[TBL] [Abstract] [Full Text] [Related]
